Inhibiting the clathrin-mediated endocytosis pathway rescues KIR2.1 downregulation by pentamidine

[1]  Mathias Meine,et al.  Beat-to-beat variability of repolarization as a new biomarker for proarrhythmia in vivo. , 2012, Heart rhythm.

[2]  Minoru Horie,et al.  A novel gain-of-function KCNJ2 mutation associated with short-QT syndrome impairs inward rectification of Kir2.1 currents. , 2012, Cardiovascular research.

[3]  D. Nassal,et al.  Molecular Determinants of Pentamidine-Induced hERG Trafficking Inhibition , 2012, Molecular Pharmacology.

[4]  M. Vos,et al.  Experimental Mapping of the Canine KCNJ2 and KCNJ12 Gene Structures and Functional Analysis of the Canine KIR2.2 ion Channel , 2012, Front. Physio..

[5]  P. Beaune,et al.  The Dynamin Chemical Inhibitor Dynasore Impairs Cholesterol Trafficking and Sterol-Sensitive Genes Transcription in Human HeLa Cells and Macrophages , 2011, PloS one.

[6]  P. Negulescu,et al.  Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809 , 2011, Proceedings of the National Academy of Sciences.

[7]  J. Clancy,et al.  Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation , 2011, Thorax.

[8]  A. Bonci,et al.  Endocytosis Promotes Rapid Dopaminergic Signaling , 2011, Neuron.

[9]  F. Aguet,et al.  Phosphatidylinositol-(4,5)-bisphosphate regulates clathrin-coated pit initiation, stabilization, and size , 2011, Molecular biology of the cell.

[10]  J. Sánchez-Chapula,et al.  Toward specific cardiac I(K1) modulators for in vivo application: old drugs point the way. , 2011, Heart rhythm.

[11]  P. Welling,et al.  Golgi Export of the Kir2.1 Channel Is Driven by a Trafficking Signal Located within Its Tertiary Structure , 2011, Cell.

[12]  M. Vos,et al.  Inhibition of lysosomal degradation rescues pentamidine-mediated decreases of K(IR)2.1 ion channel expression but not that of K(v)11.1. , 2011, European journal of pharmacology.

[13]  D. Logothetis,et al.  Cholesterol sensitivity of KIR2.1 is controlled by a belt of residues around the cytosolic pore. , 2011, Biophysical journal.

[14]  E. Melloni,et al.  Role of calpain in the regulation of CFTR (cystic fibrosis transmembrane conductance regulator) turnover. , 2010, The Biochemical journal.

[15]  M. Houtman,et al.  The mammalian KIR2.x inward rectifier ion channel family: expression pattern and pathophysiology , 2010, Acta physiologica.

[16]  D. Tester,et al.  Protein Kinase A–Dependent Biophysical Phenotype for V227F-KCNJ2 Mutation in Catecholaminergic Polymorphic Ventricular Tachycardia , 2009, Circulation. Arrhythmia and electrophysiology.

[17]  R. Neumar,et al.  Calpain Mediates Proteolysis of the Voltage-Gated Sodium Channel α-Subunit , 2009, The Journal of Neuroscience.

[18]  Ard Teisman,et al.  Blockade of the I(Ks) potassium channel: an overlooked cardiovascular liability in drug safety screening? , 2009, Journal of pharmacological and toxicological methods.

[19]  Shi-chuan Chang,et al.  Dynasore, a dynamin inhibitor, induces PAI-1 expression in MeT-5A human pleural mesothelial cells. , 2009, American journal of respiratory cell and molecular biology.

[20]  M. Matsuda,et al.  A clathrin-dependent pathway leads to KRas signaling on late endosomes en route to lysosomes , 2009, The Journal of cell biology.

[21]  P. Slesinger,et al.  Regulation of Kir2.1 channels by the Rho‐GTPase, Rac1 , 2009, Journal of cellular physiology.

[22]  Zhen Yan,et al.  Postsynaptic Density-95 (PSD-95) and Calcineurin Control the Sensitivity of N-Methyl-d-aspartate Receptors to Calpain Cleavage in Cortical Neurons , 2008, Molecular Pharmacology.

[23]  M. Vos,et al.  Lysosome mediated Kir2.1 breakdown directly influences inward rectifier current density. , 2008, Biochemical and biophysical research communications.

[24]  P. Welling,et al.  AP-2-dependent Internalization of Potassium Channel Kir2.3 Is Driven by a Novel Di-hydrophobic Signal* , 2008, Journal of Biological Chemistry.

[25]  M. Vos,et al.  Drugs and trafficking of ion channels: a new pro‐arrhythmic threat on the horizon? , 2008, British journal of pharmacology.

[26]  B. Groves,et al.  A specific role of AGS3 in the surface expression of plasma membrane proteins , 2007, Proceedings of the National Academy of Sciences.

[27]  M. Sanguinetti,et al.  Impaired interaction between the slide helix and the C-terminus of Kir2.1: a novel mechanism of Andersen syndrome. , 2007, Cardiovascular research.

[28]  A. Travis,et al.  Relationship between Kir2.1/Kir2.3 activity and their distributions between cholesterol-rich and cholesterol-poor membrane domains. , 2007, American journal of physiology. Cell physiology.

[29]  F. Cordelières,et al.  A guided tour into subcellular colocalization analysis in light microscopy , 2006, Journal of microscopy.

[30]  A. Grishin,et al.  Identification of γ-Aminobutyric Acid Receptor-interacting Factor 1 (TRAK2) as a Trafficking Factor for the K+ Channel Kir2.1* , 2006, Journal of Biological Chemistry.

[31]  T. Kirchhausen,et al.  Dynasore, a cell-permeable inhibitor of dynamin. , 2006, Developmental cell.

[32]  Marc A. Vos,et al.  Inhibition of cardiomyocyte automaticity by electrotonic application of inward rectifier current from Kir2.1 expressing cells , 2006, Medical and Biological Engineering and Computing.

[33]  M. Sanguinetti,et al.  hERG potassium channels and cardiac arrhythmia , 2006, Nature.

[34]  G. Tomaselli,et al.  Molecular basis of arrhythmias. , 2005, Circulation.

[35]  Yusong He,et al.  A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. , 2005, Biochemical and biophysical research communications.

[36]  Jun Zhou,et al.  Pentamidine reduces hERG expression to prolong the QT interval , 2005, British journal of pharmacology.

[37]  B. Fakler,et al.  Selective Golgi export of Kir2.1 controls the stoichiometry of functional Kir2.x channel heteromers , 2005, Journal of Cell Science.

[38]  S. Priori,et al.  A Novel Form of Short QT Syndrome (SQT3) Is Caused by a Mutation in the KCNJ2 Gene , 2005, Circulation research.

[39]  Y. Kuryshev,et al.  Pentamidine-Induced Long QT Syndrome and Block of hERG Trafficking , 2005, Journal of Pharmacology and Experimental Therapeutics.

[40]  C. Dart,et al.  An Alternatively Spliced Isoform of PSD-93/Chapsyn 110 Binds to the Inwardly Rectifying Potassium Channel, Kir2.1* , 2004, Journal of Biological Chemistry.

[41]  J. Yates,et al.  Protein Trafficking and Anchoring Complexes Revealed by Proteomic Analysis of Inward Rectifier Potassium Channel (Kir2.x)-associated Proteins* , 2004, Journal of Biological Chemistry.

[42]  C. Vandenberg,et al.  A Multiprotein Trafficking Complex Composed of SAP97, CASK, Veli, and Mint1 Is Associated with Inward Rectifier Kir2 Potassium Channels* , 2004, Journal of Biological Chemistry.

[43]  J. Tamargo,et al.  Pharmacology of Cardiac Potassium Channels , 2003 .

[44]  Martin Tristani-Firouzi,et al.  Defective Potassium Channel Kir2.1 Trafficking Underlies Andersen-Tawil Syndrome* , 2003, Journal of Biological Chemistry.

[45]  N. Klöcker,et al.  Surface Expression of Inward Rectifier Potassium Channels Is Controlled by Selective Golgi Export* , 2003, The Journal of Biological Chemistry.

[46]  D. Thiele,et al.  Copper-stimulated Endocytosis and Degradation of the Human Copper Transporter, hCtr1* , 2003, The Journal of Biological Chemistry.

[47]  J. Papp,et al.  Interaction of different potassium channels in cardiac repolarization in dog ventricular preparations: role of repolarization reserve , 2002, British journal of pharmacology.

[48]  Jian Yang,et al.  Alterations in Conserved Kir Channel-PIP2 Interactions Underlie Channelopathies , 2002, Neuron.

[49]  T. Schwarz,et al.  The consequences of disrupting cardiac inwardly rectifying K+ current (IK1) as revealed by the targeted deletion of the murine Kir2.1 and Kir2.2 genes , 2001, The Journal of physiology.

[50]  S. Subramony,et al.  Mutations in Kir2.1 Cause the Developmental and Episodic Electrical Phenotypes of Andersen's Syndrome , 2001, Cell.

[51]  J. Ruppersberg,et al.  A sequence motif responsible for ER export and surface expression of Kir2.0 inward rectifier K+ channels , 2001, FEBS letters.

[52]  D. A. Dougherty,et al.  Tyrosine Decaging Leads to Substantial Membrane Trafficking during Modulation of an Inward Rectifier Potassium Channel , 2001, The Journal of general physiology.

[53]  Y. Jan,et al.  Role of ER export signals in controlling surface potassium channel numbers. , 2001, Science.

[54]  T. Costantino,et al.  A prospective study of the effect of I.V. pentamidine therapy on ventricular arrhythmias and QTc prolongation in HIV-infected patients. , 1997, Chest.

[55]  E. Krause,et al.  Inhibition of K+ channels by chlorpromazine in rat ventricular myocytes. , 1994, The Journal of pharmacology and experimental therapeutics.

[56]  Allen J. Taylor,et al.  Incidence of cardiac arrhythmias during intravenous pentamidine therapy in HIV-infected patients. , 1994, Chest.

[57]  R. G. Anderson,et al.  Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation , 1993, The Journal of cell biology.

[58]  P. Sager,et al.  Pentamidine-induced torsade de pointes. , 1991, American heart journal.

[59]  P. A. Wade,et al.  Recurrent ventricular tachycardia due to pentamidine-induced cardiotoxicity. , 1988, Chest.

[60]  T. Opthof,et al.  The antiprotozoal drug pentamidine blocks KIR 2 . x-mediated inward rectifier current by entering the cytoplasmic pore region of the channelbph , 2010 .

[61]  T. Kirchhausen,et al.  Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis. , 2008, Methods in enzymology.